国产亚洲欧美二区,欧美巨大另类极品videosbest,久久国产精品偷,超刺激h直播间play

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  人才招聘  關于我們  聯系我們
萍萍的性荡生活第二部,脱了内裤猛烈进入A片视频免费,国产精品免费福利久久
首頁 > 產品中心 > 一抗 > 產品信息
Rabbit Anti-Ki-67  antibody (bs-2130R)  
~~~促銷代碼KT202411~~~
訂購熱線:400-901-9800
訂購郵箱:sales@ythxkj.com
訂購QQ:  400-901-9800
技術支持:techsupport@ythxkj.com
說明書: 50ul  100ul  
50ul/1180.00元
100ul/1980.00元
大包裝/詢價

產品編號 bs-2130R
英文名稱 Rabbit Anti-Ki-67  antibody
中文名稱 Ki67蛋白抗體
別    名 Antigen identified by monoclonal antibody Ki 67; Antigen KI67; KIA; Ki67; MKI67; Proliferation related Ki 67 antigen; Antigen KI-67; KI67_HUMAN.  
Specific References  (93)     |     bs-2130R has been referenced in 93 publications.
[IF=16.744] Zhanlin Zhang. et al. Persistent luminescence-activated Janus nanomotors with integration of photodynamic and photothermal cancer therapies. CHEM ENG J. 2022 Dec;:141226  IHC ;  Mouse.  
[IF=14.593] Guo-Bin Ding. et al. Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy. Bioact Mater. 2022 Feb;:  IHC ;  Mouse.  
[IF=14.588] Donglin Xia. et al. Au–Hemoglobin Loaded Platelet Alleviating Tumor Hypoxia and Enhancing the Radiotherapy Effect with Low-Dose X-ray. Acs Nano. 2020;14(11):15654–15668  IHC ;  Mouse.  
[IF=13.273] Long Zhao. et al. Juglone-loaded metal-organic frameworks for H2O2 self-modulating enhancing chemodynamic therapy against prostate cancer. Chem Eng J. 2022 Feb;430:133057  IHC ;  Mouse.  
[IF=13.116] Dongyang Zhao. et al. Apoptotic body–mediated intercellular delivery for enhanced drug penetration and whole tumor destruction. Sci Adv. 2021 Apr;7(16):eabg0880  IHC ;  Mouse.  
[IF=11.467] Jie Meng. et al. Pyroelectric Janus nanomotors to promote cell internalization and synergistic tumor therapy. J CONTROL RELEASE. 2023 May;357:342  IHC ;  Mouse.  
[IF=11.161] Han, Lili. et al. The RNA-binding protein GRSF1 promotes hepatocarcinogenesis via competitively binding to YY1 mRNA with miR-30e-5p. J Exp Clin Canc Res. 2022 Dec;41(1):1-18  IHC ;  Mouse.  
[IF=11.092] Junwu Wei. et al. Photothermal Propelling and Pyroelectric Potential-Promoted Cell Internalization of Janus Nanoparticles and Pyroelectrodynamic Tumor Therapy. ADV HEALTHC MATER. 2023 Mar;:2300338  IHC ;  Mouse.  
[IF=10.761] Ning Ding. et al. Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis. MATER TODAY BIO. 2023 Jun;20:100645  IHC ;  Mouse.  
[IF=10.435] Wan, Guoyun. et al. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer. J Nanobiotechnol. 2021 Dec;19(1):1-26  IF ;  Mouse.  
[IF=10.383] Yixuan Liu. et al. Engineered Magnetic Polymer Nanoparticles Can Ameliorate Breast Cancer Treatment Inducing Pyroptosis–Starvation along with Chemotherapy. ACS APPL MATER INTER. 2022;XXXX(XXX):XXX-XXX  IHC ;  Mouse.  
[IF=10.317] Qi Sun. et al. Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers. Biomaterials. 2021 Feb;269:120648  IHC ;  Mouse.  
[IF=8.355] Chen Z et al. Enzyme-powered Janus nanomotors launched from intratumoral depots to address drug delivery barriers. Chemical Engineering Journal,2019 375, 122109.  IHC ;  Mouse.  
[IF=8.355] Xie S et al. Bacteria-propelled microrockets to promote the tumor accumulation and intracellular drug uptake. Chemical Engineering Journal,2019, 123786.  IHC ;  Mouse.  
[IF=8.31] Li, Ning, et al. "Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent." Biomaterials (2014).  IHC-P ;  Mouse.  
[IF=8.31] Pan, Dayi, et al. "PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy." Biomaterials (2014).  IHC-P ;  Mouse.  
[IF=7.658] Hua-Li Wang. et al. Potential Synthetic Lethality for Breast Cancer: A Selective Sirtuin 2 Inhibitor Combined with a Multiple Kinase Inhibitor Sorafenib. Pharmacol Res. 2021 Dec;:106050  IF,IHC ;  Mouse.  
[IF=7.504] He, Nan, et al. "Tumor pH-responsive Release of Drug-conjugated Micelles from Fiber Fragments for Intratumoral Chemotherapy." ACS Applied Materials & Interfaces (2017).  other ;  
[IF=7.348] Hui Ming. et al. A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer. MATER TODAY BIO. 2022 Jun;15:100289  IHC ;  Mouse.  
[IF=6.4] Chu, Min. et al. Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis. Immun Ageing. 2022 Dec;19(1):1-17  IHC ;  Mouse.  
[IF=6.383] Xie S et al. Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.Acta Biomater. 2018 Sep 15;78:198-210.  IHC-P ;  Mouse.  
[IF=6.354] Hao, Yanan. et al. Gut microbiota-testis axis: FMT improves systemic and testicular micro-environment to increase semen quality in type 1 diabetes. MOL MED. 2022 Dec;28(1):1-17  IF ;  Mouse.  
[IF=6.304] Feng Y et al. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML)Cell Death Dis.2020 Dec 2;11(12):1025.  IHC ;  Mouse.  
[IF=6.208] Kexin Wang. et al. OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer. INT J MOL SCI. 2023 Jan;24(8):7136  IHC ;  Mouse.  
[IF=6.147] Jureepon Roboon. et al. Isolation of ferret astrocytes reveals their morphological, transcriptional, and functional differences from mouse astrocytes.. FRONT CELL NEUROSCI. 2022 Oct;16:877131-877131  ICC ;  Mouse.  
[IF=6.133] Li Xiaoping. et al. Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca2+-dependent gap junction intercellular communication. CHINESE MED J-PEKING. 2023 Feb;:10.1097/CM9.0000000000002554  IHC ;  Mouse.  
[IF=6.03] Li, Xin, Xiumei Zhu, and Liyan Qiu. "Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics." Acta Biomaterialia (2016).  IHC-P ;  Mouse.  
[IF=5.959] Hou Y et al. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma. Cell Death Dis. 2019 Dec 5;10(12):929.  IHC ;  Human.  
[IF=5.858] Rong Fu. et al. Avenanthramide C induces cellular senescence in colorectal cancer cells via suppressing β-catenin-mediated the transcription of miR-183/96/182 cluster. Biochem Pharmacol. 2022 May;199:115021  IHC ;  Human.  
[IF=5.74] Antognelli, Cinzia, et al. "Glyoxalase I drives epithelial-to-mesenchymal transition via argpyrimidine-modified Hsp70, miR-21 and SMAD signalling in human bronchial cells BEAS-2B chronically exposed to crystalline silica Min-U-Sil 5: transformation into a neoplastic-like phenotype." Free Radical Biology and Medicine (2016).  Human.  
研究領域 腫瘤  細胞生物  神經生物學  細胞周期蛋白  細胞分化  細胞類型標志物  表觀遺傳學  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human
產品應用 IHC-P=1:200-800,IHC-F=1:200-800,ICC/IF=1:100,IF=1:300-800
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 358kDa
檢測分子量 320/359?
細胞定位 細胞核 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human Ki67 
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹 Ki67 antigen is the prototypic cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2 and M phase). It is absent in resting (G0) cells. Ki67 antibodies are useful in establishing the cell growing fraction in neoplasms (immunohistochemically quantified by determining the number of Ki67 positive cells among the total number of resting cells = Ki67 index). In neoplastic tissues the prognostic value is comparable to the tritiated thymidine labelling index. The correlation between low Ki67 index and histologically low grade tumours is strong. Ki67 is routinely used as a neuronal marker of cell cycling and proliferation.

Function:
Thought to be required for maintaining cell proliferation.

Subcellular Location:
Nucleus. Chromosome. Predominantly localized in the G1 phase in the perinucleolar region, in the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix. In mitosis, it is present on all chromosomes.

Similarity:
Contains 1 FHA domain.

SWISS:
P46013

Gene ID:
4288

Database links:

Entrez Gene: 4288 Human

Entrez Gene: 17345 Mouse

Entrez Gene: 246042 Rat

Omim: 176741 Human

SwissProt: P46013 Human

SwissProt: Q91VE6 Mouse

SwissProt: Q5RJM0 Rat

Unigene: 689823 Human

Unigene: 80976 Human

Unigene: 4078 Mouse

Unigene: 233802 Rat



細胞增殖標志物(Proliferation Marker)
Ki67與PCNA一樣,為細胞增殖的一種標記,在細胞凋亡中S、G2 、M期均有表達,G0期缺如。
Ki-67增殖指數高低與許多腫瘤的分化程度、浸潤、轉移以及預后密切相關,因此被廣泛作為各種惡性腫瘤的必檢項目之一。
產品圖片
Paraformaldehyde-fixed, paraffin embedded (Human stomach); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (Ki-67) Polyclonal Antibody, Unconjugated (bs-2130R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (human lung carcinoma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (Ki-67) Polyclonal Antibody, Unconjugated (bs-2130R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded Human Tonsil; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Ki-67 Polyclonal Antibody, Unconjugated (bs-2130R) at 1:200 overnight at 4°C, followed by conjugation to the SP Kit (Rabbit, SP-0023) and DAB (C-0010) staining.
Paraformaldehyde-fixed, paraffin embedded Human ovarian serous carcinoma; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with Ki-67 Polyclonal Antibody, Unconjugated (bs-2130R) at 1:200 overnight at 4°C, followed by conjugation to the SP Kit (Rabbit, SP-0023) and DAB (C-0010) staining.
4% Paraformaldehyde-fixed Hela(H) cell; Triton X-100 at r.t. for 20 min; Antibody incubation with (Ki-67) polyclonal Antibody, unconjugated (bs-2130R) 1:100, 90 min at 37°C; followed by conjugated Goat Anti-Rabbit IgG antibody (green, bs-0295G-FITC) at 37°C for 90 min, DAPI (blue, C02-04002) was used to stain the cell nuclei. PBS instead of the primary antibody was used as the blank control.
版權所有 2004-2026 www.ythxkj.com 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號